Assignee
TAIBIDI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD
CN·0 granted patents·2 pending applications·0 citations·filing 2022–2024
Top patents by PatentIndex Score
2 records- 0154US2024374738A1Bifunctional compound capable of degrading receptor tyrosine kinase and application thereofTAIBIDI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2024·Application pending·0 cites
- 0241US2024299557A1Compound for degrading deoxyribonucleic acid (dna) polymerase, and use thereofTAIBIDI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TAIBIDI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →